Bandim Health Project
Bandim Health Project is a Danish non-profit research organization affiliated with the University of Southern Denmark that conducts observational vaccine research in Guinea-Bissau, focusing on non-specific effects of vaccines on infant health outcomes and serving academic and public health institutions.
- Company typePrivate
- Founded1978
- HeadquartersCopenhagen, Denmark
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Bandim Health Project does
Bandim Health Project is a non-profit health research organization founded in 1978 and headquartered in Copenhagen, Denmark, with operational research activities centered in Guinea-Bissau and an affiliated office in Odense, Denmark. The organization is institutionally embedded within the University of Southern Denmark, where its two principal investigators — Peter Aaby (Founder, Professor, and International Director) and Christine Stabell Benn — are based. Its core activity is observational epidemiological research on vaccines, with a specific and controversial methodological focus on the non-specific effects of vaccines on infant mortality, examining whether vaccines may influence health outcomes beyond their target diseases.
The project does not develop or sell products or services commercially. Instead, it operates on a grant-funded research model, with revenue derived from government agencies and private foundations supporting specific studies. Documented funding includes a $1.6 million unsolicited grant from the U.S. Centers for Disease Control and Prevention (awarded December 2025) for a hepatitis B vaccine trial in Guinea-Bissau, and $1.8 million from the Pershing Square Foundation (2024) for vaccine research in Africa. The organization conducts studies at scale — including a planned 14,000-infant hepatitis B vaccination trial — and serves academic and public health research institutions that consume its findings.
The organization has been the subject of sustained scientific and ethical controversy. Mainstream researchers and the World Health Organization have criticized its non-specific vaccine effects thesis, noting that other large studies (e.g., a 55,000-newborn study in Ghana and Tanzania) found BCG and DTP vaccines enhanced rather than reduced infant survival, contradicting the project's central hypothesis. In early 2026, Guinea-Bissau officials halted the CDC-funded hepatitis B vaccine trial following WHO criticism that withholding the birth dose from half of the participating babies for six weeks posed serious ethical risks, with Africa CDC initiating further ethical review. The project continues to operate as a research organization despite these controversies.
Bandim Health Project firmographics
Firmographics- Name
- Bandim Health Project
- Legal name
- Bandim Health Project
- Website
- https://bandim.org
- Company type
- Private
- Founded year
- 1978
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Bandim Health Project is a Danish non-profit research organization affiliated with the University of Southern Denmark that conducts observational vaccine research in Guinea-Bissau, focusing on non-specific effects of vaccines on infant health outcomes and serving academic and public health institutions.
- Ownership category
- akta.pro rank
Bandim Health Project industry classification
Industry- Product category
- Public Health Research
- NAICS
- Scientific Research and Development Services (5417)
- SIC
- Services-Commercial Physical & Biological Research (8731), Services-Health Services (8000)
- akta.pro primary industry
- Clinical Development & Regulatory for Vaccines (trials, pharmacovigilance, lot release) (HLAAAEAK)
- akta.pro secondary industries
- Pediatric Vaccines (HLAIAEAA), Vaccine-Preventable Disease Surveillance & Coverage Monitoring (HLAJABAK), Immunization & Vaccine Delivery Programs (BPADAIAB)
Keywords
Where Bandim Health Project is headquartered
LocationHeadquarters
- HQ city
- Copenhagen
- HQ country
- Denmark
- HQ region
- Europe
Offices2 records
Markets served
Bandim Health Project business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Infrastructure
Revenue model
- Research Grants: The organization receives grant funding from government agencies and foundations to conduct vaccine research. Major grants include $1.6 million from the CDC and $1.8 million from the Pershing Square Foundation
Bandim Health Project product offering
Product offeringCore offering
Bandim Health Project conducts epidemiological and vaccine-related public health research, primarily through a long-running Health and Demographic Surveillance System in Guinea-Bissau. The organization studies childhood morbidity, mortality, and the non-specific effects of vaccines such as BCG and DTP on infant health outcomes. It also designs and conducts vaccine trials, including a CDC-funded hepatitis B birth-dose vaccination trial.
Product overview
Bandim Health Project is a Danish health research organization affiliated with the University of Southern Denmark, led by researchers Peter Aaby and Christine Benn. The organization conducts epidemiological and vaccine research in Guinea-Bissau and other African countries. It is not a technology product company but rather a public health research initiative that has conducted studies on non-specific vaccine effects and hepatitis B vaccination trials.
Differentiator
Problem solved
Functional benefit
Products and services
- Vaccine epidemiology research (Guinea-Bissau HDSS)
- CDC-funded hepatitis B vaccine trial
Quantifiable outcome
- Study of 55,000 newborns in Ghana and Tanzania found both BCG and DTP vaccines enhanced infant survival, contradicting the Bandim Health Project thesis
Companies that use Bandim Health Project
Customer profileSegments1 record
Ideal customer profiles1 record
Bandim Health Project technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
Bandim Health Project partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- University of Southern DenmarkcoreThe Bandim Health Project researchers are based at the University of Southern Denmark. Researchers Christine Stabell Benn and Peter Aaby lead the project through this academic institution, which provides institutional affiliation and research infrastructure.
Scale indicators4 records
Recent moves5 records
Expansion highlights4 records
Bandim Health Project competitors and assessment
Company assessmentOthers
- INDEPTH Network: International network of health and demographic surveillance system sites across Africa and Asia; Bandim is a member-type site, and INDEPTH is the umbrella that convenes similar longitudinal research platforms.
- WHO Special Programme for Research and Training in Tropical Diseases (TDR): UN-hosted research programme funding and coordinating infectious disease and vaccine research in low- and middle-income countries; serves as an ecosystem counterpart and potential funder/critic of Bandim's work.
Direct peers
- KEMRI-Wellcome Trust Research Programme: Kenya-based clinical and epidemiological research programme running health and demographic surveillance and vaccine trials in sub-Saharan Africa, directly comparable in scope and methodology to Bandim.
- African Population and Health Research Center (APHRC): Africa-based non-profit research organization conducting population and health research with field sites in low-income African settings, with a comparable funding model (grants, foundations) and academic affiliations.
- MRC Unit The Gambia at LSHTM: Long-running West Africa-based epidemiological and vaccine research unit operating a demographic surveillance system similar to Bandim's Guinea-Bissau platform, with comparable study designs on infant vaccine outcomes.
- Navrongo Health Research Centre: Ghana Health Service research centre operating one of Africa's oldest HDSS platforms and conducting vaccine and child-health intervention trials in a high-disease-burden West African setting similar to Guinea-Bissau.
Regional players
- Statens Serum Institut: Danish national public health and vaccine research institute that collaborates closely with Bandim researchers on non-specific vaccine effects research, sharing geographic and institutional ties though operating at far greater scale in Denmark.
Broad incumbents
- London School of Hygiene & Tropical Medicine (LSHTM): Major global public health research university that operates the MRC Unit The Gambia; offers overlapping vaccine epidemiology research capacity at much larger scale and serves as a parent institution for several Africa HDSS platforms.
Market position
Strengths4 records
Weaknesses5 records
Competitive moat3 records
Key risks6 records
Key highlights6 records
Customer concentration
Bandim Health Project social profiles
Digital presenceBandim Health Project financial estimates
Financial estimateRevenue estimate
Valuation estimate
Bandim Health Project leadership team
Management profileNumber of profiles
Profiles1 record
Bandim Health Project funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Bandim Health Project M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Bandim Health Project
What does Bandim Health Project do?
Bandim Health Project conducts epidemiological and vaccine-related public health research, primarily through a long-running Health and Demographic Surveillance System in Guinea-Bissau. The organization studies childhood morbidity, mortality, and the non-specific effects of vaccines such as BCG and DTP on infant health outcomes. It also designs and conducts vaccine trials, including a CDC-funded hepatitis B birth-dose vaccination trial.
Is Bandim Health Project a public or private company?
Bandim Health Project is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was Bandim Health Project founded?
Bandim Health Project was founded in 1978. It employs 11 to 50 people.
Where is Bandim Health Project based?
Bandim Health Project is headquartered in Copenhagen, Denmark, in the Europe region.
How does Bandim Health Project make money?
One revenue line is on record: research Grants.
Who are Bandim Health Project's main competitors?
Others on record are INDEPTH Network and WHO Special Programme for Research and Training in Tropical Diseases (TDR). Direct peers are KEMRI-Wellcome Trust Research Programme, African Population and Health Research Center (APHRC), MRC Unit The Gambia at LSHTM and Navrongo Health Research Centre. Statens Serum Institut is listed as a regional player. London School of Hygiene & Tropical Medicine (LSHTM) is listed as a broad incumbent.
Does Bandim Health Project have an API?
No public API is recorded for Bandim Health Project.
What industry is Bandim Health Project in?
Bandim Health Project's product category is Public Health Research. Its primary akta.pro industry code is HLAAAEAK, Clinical Development & Regulatory for Vaccines (trials, pharmacovigilance, lot release), with a secondary code of HLAIAEAA, Pediatric Vaccines. Its NAICS code is 5417 and its SIC code is 8731.